5th Öresund Peptide Symposium: 24 September 2026
Our CSO Christian Kjellman presents "TCP-25: An Immunomodulatory Peptide in Phase 2/3 Development for Dysregulated Inflammation in Epidermolysis Bullosa Wounds" at the 5th Öresund Peptide Symposium at Medicon Village.
The symposium brings together the peptide community from industry and academia, and we look forward to contributing to the discussions around peptide-based drug development.
